Skip to main content

Experimental Approaches for Testing the Cholinergic-Noradrenergic Imbalance Hypothesis of Affective Disorders

  • Conference paper
Neuropsychopharmacology

Abstract

The hypothesis of a cholinergic-/aminergic transmitter imbalance as the cause of manic-depressive disorders, formulated by Janowsky and coworkers (Janowsky et al. 1972; Janowsky and Risch 1986), is based on the observation that biological systems, such as heart rate, blood pressure, body temperature, and extrapyramidal system, are regulated by at least two transmitter systems in reciprocal interaction. It seemed reasonable to extend the amine deficiency hypothesis of depression to an imbalance model between the aminergic and cholinergic central transmitter systems (Berger 1985, 1987).

Supported by a grant from the Deutsche Forschungsgemeinschaft (SFB 258, Teilprojekt B/M).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Ansseau M, Scheyvaerts M, Doumont A, Poirrier R, Legros JJ, Franck G (1984) Concurrent use of REM latency, dexamethasone suppression, clonidine, and apomorphine tests as biological markers of endogenous depression: a pilot study. Psychiatry Res 12: 261–272

    Article  PubMed  CAS  Google Scholar 

  • Ansseau M, Frenckell R von, Cerfontaine JL, Papart P, Franck G, Timsit-Berthier M, Geenen V, Legros JJ (1987) Neuroendocrine evaluation in catecholaminergic neurotrans-mission in mania. Psychiatry Res 22: 193–206

    Article  PubMed  CAS  Google Scholar 

  • Beersma DGM, Daan S, Hoofdakker RH van den (1984) Sleep structure in depression. Exp Brain Res 8: 285–296

    Article  Google Scholar 

  • Berger M (1985) Vergleichende psychobiologische Untersuchungen bei enogenen und neurotischen Depressionen. Thesis, University of Munich

    Google Scholar 

  • Berger M (1987) Schlaf-EEG Studien zum aminerg-cholinergen Imbalance-Modell depressiver Erkrankungen. In: Angst J, Gastpar M (eds) Depression - Schlaf - Traum. Panscientia, Hedingen, Zürich, pp 38–51

    Google Scholar 

  • Berger M, Doerr P, Lund R, Bronisch T, Zerssen D von (1982) Neuroendocrinological and neurophysiological studies in major depressive disorders: are there biological markers for the endogenous subtype? Biol Psychiatry 17: 1217–1242

    PubMed  CAS  Google Scholar 

  • Berger M, Lund R, Bronisch T, Zerssen D von (1983) REM latency in neurotic and endogenous depression and the cholinergic REM induction test. Psychiatry Res 10:113– 123

    Google Scholar 

  • Berger M, Pirke KM, Doerr P, Krieg JC, Zerssen D von (1984) The limited utility of the dexamethasone suppression test for the diagnostic process in psychiatry. Br J Psychiatry 145: 372–382

    Article  PubMed  CAS  Google Scholar 

  • Berger M, Riemann D, Höchli D, Spiegel R (1989) The cholinergic REM induction test with RS 86: state or trait marker of depression? Arch Gen Psychiatry 46: 421–428

    Article  PubMed  CAS  Google Scholar 

  • Bunney WE Jr, Goodwin FK, Murphy DL, House GM, Gordon EK (1972) The “switch process” in manic-depressive illness. II. Relationship to catecholamines, REM sleep, and drugs. Arch Gen Psychiatry 27: 304–309

    Google Scholar 

  • Checkley SA, Slade AP, Shur E (1981) Growth hormone and other responses to Clonidine in patients with endogenous depression. Br J Psychiatry 138: 51–55

    Article  PubMed  CAS  Google Scholar 

  • Delitala G, Maioli M, Pacifico A, Brianda S, Palermo M, Mannelli M (1983) Cholinergic receptor control mechanisms for L-dopa, apomorphine, and clonidine-induced growth hormone secretion in man. J Clin Endocrinol Metab 57: 1145–1149

    Article  PubMed  CAS  Google Scholar 

  • Doerr P, Berger M (1983) Physostigmine induced escape from dexamethasone suppression in normal adults. Biol Psychiatry 18: 261–267

    PubMed  CAS  Google Scholar 

  • Doerr P, von Zerssen D, Fischler M, Schulz H (1979) Relationship between mood changes and adrenal cortical activity in a patient with a 48-hour unipolar depressive cycle. J Affective Disord 1: 93–104

    Article  CAS  Google Scholar 

  • Gilbert P (1984) Depression: from psychology to brain state. Lawrence Erlbaum, Hillsdale

    Google Scholar 

  • Hobson JA, Steriade M (1986) Neuronal basis of behavioural state control. In: Mountcastle VB, Bloom FE, Geiger SR (eds) Intrinsic regulatory systems of the brain. American Physiological Society Bethesda, pp 701-823 (Handbook of physiology, vol 4 )

    Google Scholar 

  • Hobson JA, McCarley RW, McKenna TM (1976) Cellular evidence bearing on the pontine brainstem hypothesis of desynchronized sleep control. Prog Neurobiol 6: 280–285

    Google Scholar 

  • Hoehe M, Valido G, Matussek, N (1988) Growth hormone, noradrenaline, blood pressure and Cortisol responses to Clonidine in healthy male volunteers: dose-response relations and reproducibility. Psychoneuroendocrinology 13: 409–418

    Article  PubMed  CAS  Google Scholar 

  • Hudson JI, Lipinski JF, Frankenburg FR, Grochocinski VJ, Kupfer DJ (1989) Electroen- cephalographic sleep in mania. Arch Gen Psychiatry 45: 267–273

    Article  Google Scholar 

  • Janowsky DS, Risch SC (1986) Adrenergic-cholinergic balance and affective disorders. In: Rush AJ, Altshuler KZ (eds) Depression - basic mechanisms, diagnosis, and treatment. Guilford, New York, pp 84–101

    Google Scholar 

  • Janowsky DS, El-Yousef MK, Davis JM, Sekerke HJ (1972) A cholinergic noradrenergic hypothesis of mania and depression. Lancet 2: 632–635

    Article  PubMed  CAS  Google Scholar 

  • Janowsky DS, Risch SC, Jedd LL, Parker DC, Kalin NH, Huey LJ (1983) Behavioral and neuroendocrine effects of physostigmine in affective disorder patients. In: Clayton PJ, Barret JE (eds) Treatment of depression: old controversies and new approaches. Raven, New York, pp 61–74

    Google Scholar 

  • Krieg JC, Berger M (1986) Cholinergic influence on manic symptoms. Clin Neuropharmacol 9: 544–546

    PubMed  Google Scholar 

  • Krieg JC, Bossert S, Pirke KM, Zerssen D von, Berger M (1987) The influence of the muscarinic agonist RS 86 on the Cortisol system. Biol Psychiatry 2: 573–582

    Article  Google Scholar 

  • Kupfer DJ, Henninger GR (1972) REM activity as a correlate of mood changes throughout the night. Arch Gen Psychiat 27: 368–373

    Article  PubMed  CAS  Google Scholar 

  • Lauer C, Zulley J, Krieg JC, Riemann D, Berger M (1988) EEG sleep and the cholinergic REM induction test in anorexia and bulimic patients. Psychiatry Res 26: 171–181

    Article  PubMed  CAS  Google Scholar 

  • Matussek N (1988) Catecholamines and mood: neuroendocrine aspects. In: Granten D, Pfaff D, Fuxe K (eds) Current topics in neuroendocrinology, vol 8, pp 141–182, Springer, Berlin Heidelberg New York

    Google Scholar 

  • Matussek N, Ackenheil M, Hippius H, Müller F, Schröder HT, Schultes H, Wasilewski B (1980) Effect of Clonidine on growth hormone release in psychiatric patients and controls. Psychiatry Res 2: 25–36

    Article  PubMed  CAS  Google Scholar 

  • McCarley RW (1982) REM sleep and depression: common neurobiological control mechanisms. Am J Psychiatry 139:565–570

    Google Scholar 

  • Palacios JM, Bollinger G, Closse A, Enz A, Gmelin G, Malanowski J (1986) The pharmacological assessment of RS 86 (2-ethyl-8-methyl-2,8-diazaspiro(4,5-decan- 1,3-dion hydrobromide). A potent, specific muscarinic acetylcholine receptor agonist. Eur J Pharmacol 125: 45–62

    Google Scholar 

  • Post RM (1987) Mechanisms of action of carbamazepine and related anticonvulsants in affective illness. In: Meitzer HY (ed) Psychopharmacology: the third generation of progress. Raven, New York, pp 567–576

    Google Scholar 

  • Rechtschaffen A, Kales A (1968) Manual of standardized terminology techniques and scoring system for sleep stages of human subjects. National Institute of Health Publications 204. US Government Printing Office, Washington DC

    Google Scholar 

  • Riemann D, Berger M (1989) EEG sleep in depression and remission and the cholinergic REM induction response to RS 86. Neuropsychopharmacology 2: 145–152

    Article  PubMed  CAS  Google Scholar 

  • Riemann D, Joy D, Höchli D, Lauer C, Zulley J, Berger M (1988) Influence of the cholinergic agonist RS 86 on normal sleep: sex and age effects. Psychiatry Res 24: 137–147

    Article  PubMed  CAS  Google Scholar 

  • Siever LJ, Uhde TW (1984) New studies and perspectives on the noradrenergic receptor system in depression. Effects of the alpha2-adrenergic agonist Clonidine. Biol Psychiatry 19: 131–156

    PubMed  CAS  Google Scholar 

  • Sitaram N, Moore AM, Gillin JC (1978 a) Experimental acceleration and slowing of REM sleep ultradian rhythm by cholinergic agonist and antagonist. Nature 274: 490–492

    Google Scholar 

  • Sitaram N, Moore AM, Gillin JC (1978 b) Induction and resetting of REM sleep rhythm in normal man by arecholine: blockade by scopolamine. Sleep 1: 83–90

    Google Scholar 

  • Sitaram N, Moore AM, Gillin JC (1979) Scopolamine induced muscarinic supersensitivity in normal man: changes in sleep. Psychiatry Res 1: 9–16

    Article  PubMed  CAS  Google Scholar 

  • Sitaram N, Gillin JC, Bunney WE (1984) Cholinergic and catecholaminergic receptor sensitivity in affective illness: Strategy and theory. In: Post RM, Ballenger JC (eds) Neurobiology of mood disorders. Williams and Wilkins, Baltimore, pp 629–651

    Google Scholar 

  • Spiegel R (1984) Effects of RS 86, an orally active cholinergic agonist, on sleep in man. Psychiatry Res 11: 1–13

    Article  PubMed  CAS  Google Scholar 

  • Van Loon GR (1973) Catecholamines and ACTH secretion. In: Ganong WF, Martin L (eds) Frontiers in neuroendocrinology. Oxford University Press, New York, pp 209–247

    Google Scholar 

  • Vogel GW, Vogel E, McAbee RS, Thurmond A J (1980) Improvement of depression by REM sleep deprivation. Arch Gen Psychiatry 37: 247–253

    Article  PubMed  CAS  Google Scholar 

  • Zerssen D von (1986) Clinical self-rating scales (CSRS) of the Munich psychiatry information system (PSYCHIS München). In: Sartorius N, Ban T (eds) Assessment of depression. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Zerssen D von, Lund R, Doerr P, Fischler M, Emrich HM, Ploog D (1979) 48-hour-cycles of depression and their biological concomitants with and without “Zeitgebers”. A case report. In: Saletu B, Berner P, Hollister L (eds) Neuropsychopharmacology. Pergamon, Oxford, pp 233–245

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Berger, M., Fleckenstein, P., Riemann, D., Müller, W.E. (1990). Experimental Approaches for Testing the Cholinergic-Noradrenergic Imbalance Hypothesis of Affective Disorders. In: Bunney, W.E., Hippius, H., Laakmann, G., Schmauss, M. (eds) Neuropsychopharmacology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74034-3_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-74034-3_21

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-74036-7

  • Online ISBN: 978-3-642-74034-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics